241 related articles for article (PubMed ID: 16890804)
41. Truncated G-Quadruplex Isomers Cross-Talk with the Transcription Factors To Maintain Homeostatic Equilibria in c-MYC Transcription.
Sengupta P; Bhattacharya A; Sa G; Das T; Chatterjee S
Biochemistry; 2019 Apr; 58(15):1975-1991. PubMed ID: 30920805
[TBL] [Abstract][Full Text] [Related]
42. The c-myc promoter: still MysterY and challenge.
Wierstra I; Alves J
Adv Cancer Res; 2008; 99():113-333. PubMed ID: 18037408
[TBL] [Abstract][Full Text] [Related]
43. Spontaneous DNA lesions modulate DNA structural transitions occurring at nuclease hypersensitive element III(1) of the human c-myc proto-oncogene.
Beckett J; Burns J; Broxson C; Tornaletti S
Biochemistry; 2012 Jul; 51(26):5257-68. PubMed ID: 22667821
[TBL] [Abstract][Full Text] [Related]
44. Quinazoline derivative QPB-15e stabilizes the c-myc promoter G-quadruplex and inhibits tumor growth in vivo.
Li Z; Liu C; Huang C; Meng X; Zhang L; He J; Li J
Oncotarget; 2016 Jun; 7(23):34266-76. PubMed ID: 27144522
[TBL] [Abstract][Full Text] [Related]
45. Expression of human beta-defensin 1 is regulated via c-Myc and the biological clock.
Sherman H; Froy O
Mol Immunol; 2008 Jun; 45(11):3163-7. PubMed ID: 18433872
[TBL] [Abstract][Full Text] [Related]
46. Turning off transcription of the bcl-2 gene by stabilizing the bcl-2 promoter quadruplex with quindoline derivatives.
Wang XD; Ou TM; Lu YJ; Li Z; Xu Z; Xi C; Tan JH; Huang SL; An LK; Li D; Gu LQ; Huang ZS
J Med Chem; 2010 Jun; 53(11):4390-8. PubMed ID: 20481493
[TBL] [Abstract][Full Text] [Related]
47. Growth factor-dependent regulation of survivin by c-myc in human breast cancer.
Cosgrave N; Hill AD; Young LS
J Mol Endocrinol; 2006 Dec; 37(3):377-90. PubMed ID: 17170079
[TBL] [Abstract][Full Text] [Related]
48. Not all G-quadruplexes are created equally: an investigation of the structural polymorphism of the c-Myc G-quadruplex-forming sequence and its interaction with the porphyrin TMPyP4.
Le HT; Miller MC; Buscaglia R; Dean WL; Holt PA; Chaires JB; Trent JO
Org Biomol Chem; 2012 Dec; 10(47):9393-404. PubMed ID: 23108607
[TBL] [Abstract][Full Text] [Related]
49. Small-molecule interaction with a five-guanine-tract G-quadruplex structure from the human MYC promoter.
Phan AT; Kuryavyi V; Gaw HY; Patel DJ
Nat Chem Biol; 2005 Aug; 1(3):167-73. PubMed ID: 16408022
[TBL] [Abstract][Full Text] [Related]
50. The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo.
Grand CL; Han H; Muñoz RM; Weitman S; Von Hoff DD; Hurley LH; Bearss DJ
Mol Cancer Ther; 2002 Jun; 1(8):565-73. PubMed ID: 12479216
[TBL] [Abstract][Full Text] [Related]
51. Anticancer activity and cellular repression of c-MYC by the G-quadruplex-stabilizing 11-piperazinylquindoline is not dependent on direct targeting of the G-quadruplex in the c-MYC promoter.
Boddupally PV; Hahn S; Beman C; De B; Brooks TA; Gokhale V; Hurley LH
J Med Chem; 2012 Jul; 55(13):6076-86. PubMed ID: 22691117
[TBL] [Abstract][Full Text] [Related]
52. Wild-type p53 binds to MYC promoter G-quadruplex.
Petr M; Helma R; Polášková A; Krejčí A; Dvořáková Z; Kejnovská I; Navrátilová L; Adámik M; Vorlíčková M; Brázdová M
Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27634752
[TBL] [Abstract][Full Text] [Related]
53. Expression of the TAF4b gene is induced by MYC through a non-canonical, but not canonical, E-box which contributes to its specific response to MYC.
Teye K; Okamoto K; Tanaka Y; Umata T; Ohnuma M; Moroi M; Kimura H; Tsuneoka M
Int J Oncol; 2008 Dec; 33(6):1271-80. PubMed ID: 19020761
[TBL] [Abstract][Full Text] [Related]
54. Keratinocyte transcriptional regulation of the human c-Myc promoter occurs via a novel Lef/Tcf binding element distinct from neoplastic cells.
Kolly C; Zakher A; Strauss C; Suter MM; Müller EJ
FEBS Lett; 2007 May; 581(10):1969-76. PubMed ID: 17466981
[TBL] [Abstract][Full Text] [Related]
55. [Silencing of c-myc gene expression by enzymatically and chemically synthesized siRNAs].
Kabilova TO; Vladimirova AV; Repkova MN; Ven'iaminova AG; Chernolovskaia EL; Vlasov VV
Mol Biol (Mosk); 2006; 40(6):1037-46. PubMed ID: 17209432
[TBL] [Abstract][Full Text] [Related]
56. Characterization of the G-quadruplexes in the duplex nuclease hypersensitive element of the PDGF-A promoter and modulation of PDGF-A promoter activity by TMPyP4.
Qin Y; Rezler EM; Gokhale V; Sun D; Hurley LH
Nucleic Acids Res; 2007; 35(22):7698-713. PubMed ID: 17984069
[TBL] [Abstract][Full Text] [Related]
57. c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation.
Vaqué JP; Fernández-García B; García-Sanz P; Ferrandiz N; Bretones G; Calvo F; Crespo P; Marín MC; León J
Mol Cancer Res; 2008 Feb; 6(2):325-39. PubMed ID: 18314492
[TBL] [Abstract][Full Text] [Related]
58. Heart-specific inhibition of protooncogene c-myc attenuates cold-induced cardiac hypertrophy.
Bello Roufai M; Li H; Sun Z
Gene Ther; 2007 Oct; 14(19):1406-16. PubMed ID: 17637797
[TBL] [Abstract][Full Text] [Related]
59. G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription.
Cogoi S; Xodo LE
Nucleic Acids Res; 2006; 34(9):2536-49. PubMed ID: 16687659
[TBL] [Abstract][Full Text] [Related]
60. Cell growth suppression by thanatos-associated protein 11(THAP11) is mediated by transcriptional downregulation of c-Myc.
Zhu CY; Li CY; Li Y; Zhan YQ; Li YH; Xu CW; Xu WX; Sun HB; Yang XM
Cell Death Differ; 2009 Mar; 16(3):395-405. PubMed ID: 19008924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
